Bluejay Diagnostics (BJDX) Long-Term Debt Issuances (2021)
Bluejay Diagnostics (BJDX) posted Long-Term Debt Issuances of -$4.2 million for Q4 2021, down 380.69% sequentially from $1.5 million in Q3 2021.
Bluejay Diagnostics (BJDX) Long-Term Debt Issuances (2021) Analysis & Trends
Bluejay Diagnostics has reported Long-Term Debt Issuances for 1 years, with the latest figure at -$4.2 million in Q4 2021.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to -$4.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2024 was -$2.7 million (changed N/A YoY) and the FY2024 annual result came in at $2.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances fell to -$4.2 million in Q4 2021 per BJDX's latest filing, from $1.5 million in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $2.7 million in Q2 2021 and troughed at -$4.2 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -33.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 109.26 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -4.21 Mn |
| Dec 31, 2021 | -4.21 Mn |
| Sep 30, 2021 | 1.50 Mn |
| Sep 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 2.73 Mn |
| Jun 30, 2021 | 2.73 Mn |
| Mar 31, 2021 | 268,000.00 |
| Mar 31, 2021 | 268,000.00 |